Anticoagulant for primary percutaneous coronary intervention - The last dance for unfractionated heparin?

Archives of Cardiovascular Diseases

Volumn 105, Issue 5, 2012, Pages 259-261

  Silvain, Johanne ^a,b   Montalescot, Gilles ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Anticoagulants; Anticoagulation; Bivalirudin; Heparin; Low molecular weight heparin; Myocardial infarction

Indexed keywords

ANTICOAGULANT AGENT; CLOPIDOGREL; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRULOG; PRASUGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; BLEEDING; CLINICAL PRACTICE; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84862888982     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2012.03.002     Document Type: Article

References (8)

1. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-62.
2. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30.
3. Romagnioli E. Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome (RIFLE STEACS). TCT. San Francisco; 2011.
4. Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA 2006;295:1519-30.
5. Montalescot G, Zeymer U, Silvain J, et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet 2011;378:693-703.
6. Navarese EP, De Luca G, Castriota F, et al. Low-molecularweight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. J Thromb Haemost 2011;9:1902-15.
7. Silvain J, Beygui F, Barthelemy O, et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ 2012;344:e553.
8. Montalescot G, Borentain M, Payot L, Collet JP, Thomas D. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute STsegment elevation myocardial infarction: a meta-analysis. JAMA 2004;292:362-6.